Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Learn how value tilts steer retirement portfolio index funds toward undervalued opportunities, balancing risk while pursuing higher long-term gains.
25,656 articlesInvestors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
A star-studded film-event launch is shaping how fans experience new music—and it doubles as a case study in smart mon...
Berkshire Hathaway has resumed stock buybacks, purchasing $15 million of its own shares. CEO Greg Abel personally bou...
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
AI is reshaping how businesses operate. This guide argues why a select software stock fits a once-in-a-decade opportu...
A tech giant lanes three high-margin engines—cloud, ads, and subscriptions—on a profitable retail base, challenging m...
Strategy MSTR short interest is rising as bearish bets mount, challenging the narrative around the companys Bitcoin s...
Inflation has squeezed most Americans, but American Express remains focused on the affluent. This article examines wh...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
Rising memory costs are pushing Apple to raise prices higher. This article examines how that could affect margins, de...
Backlogs can power stock moves, but they also raise questions about execution, risk, and long-term profitability. Thi...
SpaceX's $7.7 billion AI infrastructure push in Q1 2026 marks a dramatic shift from traditional rocket business to da...